Cline Christopher R. sold TVTX
February 4, 2026 · Form 4 insider transaction
Cline Christopher R. sold 110 shares of Travere Therapeutics, Inc. at $32.90 per share, a transaction worth $3.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
110
Price
$32.90
Total value
$3.6K
InsiderCline Christopher R.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 4, 2026
Filing dateFebruary 5, 2026
Shares owned after111,226
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.